Share
Market Research Report

TRANSGENIC ANIMAL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Animal TypeMice · Rats · Zebrafish · Pigs · Cattle · Sheep · Goats · Chickens · and Others (Non-human primates rabbits)
  • By TechnologyMicroinjection · Embryonic Stem Cell (ESC) Injection · Nuclear Transfer (Cloning) · CRISPR/Cas9 and Other Gene Editing Technologies · and Viral Vector-mediated Transgenesis
  • By ApplicationBiomedical Research · Drug Discovery and Development · Toxicology and Safety Testing · Disease Modeling · Regenerative Medicine · Xenotransplantation · Biopharmaceutical Production · and Agricultural Trait Enhancement
  • By Disease AreaOncology · Neurological Disorders · Cardiovascular Diseases · Metabolic Disorders · Immunological and Autoimmune Diseases · Genetic and Rare Diseases · and Infectious Diseases
  • By End UserAcademic and Research Institutes · Pharmaceutical Companies · Biotechnology Companies · Contract Research Organizations (CROs) · Agricultural Research Organizations · and Government and Regulatory Laboratories
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In01 Apr 2026
  • Report CodeCMI9092
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Animal Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Mice
    • Rats
    • Zebrafish
    • Pigs
    • Cattle
    • Sheep
    • Goats
    • Chickens
    • Others (Non-human primates rabbits)
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)

    • Microinjection
    • Embryonic Stem Cell (ESC) Injection
    • Nuclear Transfer (Cloning)
    • CRISPR/Cas9 and Other Gene Editing Technologies
    • Viral Vector-mediated Transgenesis
  • Application Insights (Revenue, USD Bn, 2021 - 2033)

    • Biomedical Research
    • Drug Discovery and Development
    • Toxicology and Safety Testing
    • Disease Modeling
    • Regenerative Medicine
    • Xenotransplantation
    • Biopharmaceutical Production
    • Agricultural Trait Enhancement
  • Disease Area Insights (Revenue, USD Bn, 2021 - 2033)

    • Oncology
    • Neurological Disorders
    • Cardiovascular Diseases
    • Metabolic Disorders
    • Immunological and Autoimmune Diseases
    • Genetic and Rare Diseases
    • Infectious Diseases
  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Academic and Research Institutes
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Agricultural Research Organizations
    • Government and Regulatory Laboratories
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa